Records containing: Tuberculosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-10-08A Phase 1, Drug-Drug Interaction Study to Evaluate the Safety, Tolerability, and the Induction Potential of TBAJ-876 on CYP3A4 and P-glycoprotein and the Inhibition Potential of TBAJ-876 on P-glycoprotein in Healthy Adult Subjects
-
CLINICAL_TRIALS study record update · 2024-10-01Two-site Laboratory-based Diagnostic Accuracy and Feasibility Study of the Xpert MTB/XDR Assay for Detection of Isoniazid, Fluoroquinolone, Ethionamide and Second-line Injectable Anti-tuberculosis Drug Resistance
-
CLINICAL_TRIALS study record update · 2024-10-01Study on the Safety of Administering Isoniazid to Systemic Lupus Erythematosus Patients to Prevent Tuberculosis
-
CLINICAL_TRIALS study record update · 2024-09-26Evaluation of a CD4/CD8+ Interferon Gamma Release Assay for Monitoring Anti-Tuberculosis Treatment
-
CLINICAL_TRIALS study record update · 2024-09-26Detection of Lipoarabinomannan in Urine, Evaluation of the STANDARDTM F TB LAM FIA and Its Impact on the Initial Diagnosis of TB
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-09-19Evaluation and Validation of Novel Immunodiagnostic Tests for Childhood Tuberculosis Infection and Disease in Switzerland. The CITRUS (ChIldhood TubeRcUlosis in Switzerland) Study.
-
CLINICAL_TRIALS study record update · 2024-09-19An Open-Label Phase 2 Trial to Evaluate the Male Reproductive Safety of a 6-Month Combination Treatment for Pulmonary Tuberculosis (TB) of Bedaquiline Plus Pretomanid Plus Moxifloxacin Plus Pyrazinamide (BPaMZ) in Adult Male Participants With Drug Resistant Pulmonary TB
-
CLINICAL_TRIALS study record update · 2024-09-04Effect of Endurance Training On Functional Capacity and Quality of Life in Patients With Post-TB Lung Disease
-
CLINICAL_TRIALS study record update · 2024-08-30The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis From Healthy Blood Donors and Patients With Latent or Active Tuberculosis.
-
CLINICAL_TRIALS study record update · 2024-08-29Efficacy and Safety of an Initial Regimen Raltegravir (RAL) + Lamivudine/Abacavir Fixed-Dose Combination (3TC/ABC FDC) for 48 Weeks in ART- naïve, HIV/TB Co-Infected Adult Subjects Receiving Rifabutin-containing, 1-line Anti-TB Therapy
-
CLINICAL_TRIALS study record update · 2024-08-28An Open Label, Randomized Controlled Trial to Establish the Efficacy and Safety of a Study Strategy Consisting of 6 Months of Bedaquiline (BDQ), Delamanid (DLM), and Linezolid (LNZ), With Levofloxacin (LVX) and Clofazimine (CFZ) Compared to the Current South African Standard of Care (Control Strategy) for 9 Months for the Treatment of Rifampicin Resistant Tuberculosis (RR-TB)
-
CLINICAL_TRIALS study record update · 2024-08-23Comparing Gene Expression Profiles of Adults With Isolated Spinal TB to Disseminated Spinal TB Identified by 18FDG-PET/CT at Time of Diagnosis, 6-and 12-months Follow-up
-
CLINICAL_TRIALS study record update · 2024-08-21Frequency of Tuberculosis in Psoriasis Patients Using Anti-TNF Therapy During 15 Years of Follow-up.
-
CLINICAL_TRIALS study record update · 2024-08-13Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin
-
CLINICAL_TRIALS study record update · 2024-08-12Optimization of Tuberculosis Diagnosis and Management Using Four Immunological Biomarkers
-
CLINICAL_TRIALS study record update · 2024-08-09Inpatient Package to Reduce HIV and AIDS-related Death in Zambia
-
CLINICAL_TRIALS study record update · 2024-08-07Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
-
CLINICAL_TRIALS study record update · 2024-08-07Prospective Evaluation of Novel Diagnostics for Tuberculosis in KwaZulu-Natal, South Africa
-
CLINICAL_TRIALS study record update · 2024-07-26A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) Trial in Healthy Adults to Evaluate the Safety, Tolerability, and PK of MK-7762
-
CLINICAL_TRIALS study record update · 2024-07-26Mycobacteria Registry Study: Prospective Observational Study in Austria
-
CLINICAL_TRIALS study record update · 2024-07-25Impact Evaluation of Use of MATCH AI Predictive Modelling for Identification of Hotspots for TB Active Case Finding in Pakistan: a Pragmatic Stepped Wedge Cluster Randomized Trial
-
CLINICAL_TRIALS study record update · 2024-07-22Isoniazid Prophylaxis Based on Risk Factors of Tuberculosis in Living Kidney Transplantation Recipients: A Retrospective Cohort Study
-
CLINICAL_TRIALS study record update · 2024-07-19eNose-TB: Electronic Nose for Tuberculosis Screening in Indonesia
-
CLINICAL_TRIALS study record update · 2024-07-16A Randomized Controlled Trial to Evaluate a Scalable Active Case Finding Intervention for TB Using a Point-of-care Molecular Tool (Gene Xpert)
-
CLINICAL_TRIALS study record update · 2024-07-12A Phase 3, Open-label, Dose Escalation Study to Determine the Pharmacokinetics of Atazanavir Administered With RIfampicin to HIV Positive Adults on sEcond-line ART Regimen With Suppressed HIV-1 Viral Load (DERIVE)